Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16544528 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL18924419 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL18924420 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL12237367 | 0.96 | LMNA (0.39) | LMNATHRB | |
| SCHEMBL20758033 | 0.88 | — | — | |
| SCHEMBL20805469 | 0.88 | — | — | |
| SCHEMBL22855974 | 0.88 | — | — | |
| SCHEMBL20812330 | 0.88 | — | — | |
| SCHEMBL20805470 | 0.88 | — | — | |
| SCHEMBL20805467 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20180179120-A1 | Atropisomers and Methods of Altering Enantiomeric Excess | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-06-28 | — | — | US | disclosed |
| US-20180179120-A1 | Atropisomers and Methods of Altering Enantiomeric Excess | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | LMNA 2531/4885THRB 4583/4885CA2 3219/4885 |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EMC1, EMC2, EPCAM | LMNA 2531/4885THRB 4583/4885CA2 3219/4885 |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, AOC1 | LMNA 2644/4885THRB 4639/4885CA2 3086/4885 |
| US-20180179120-A1 | Atropisomers and Methods of Altering Enantiomeric Excess | CYP11B2, CYP21A2, CYP11B1 | LMNA 2207/4885THRB 1702/4885CA2 3574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.